Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.20), $0.14 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.11 million versus the consensus estimate of $2.5 million.

For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.